38424 Federal Register / Vol. 63, No. 136 /Thursday, July 16, 1998 / Notices

44114–2600, at the Region 5 Office of

the Environmental Protection Agency,

77 West Jackson Street, Chicago, Illinois

60604–3590, and at the Consent Decree

Library, 1120 G Street, NW., 4th Floor,

Washington, DC 20005, (202) 624–0892.

A copy of the proposed Consent Decree

may be obtained in person or by mail

from the Consent Decree Library, 1120

G Street, NW., 4th Floor, Washington,

DC 20005. In requesting a copy, please

enclose a check in the amount of $19.75

(25 cents per page reproduction cost)

payable to the Consent Decree Library.

Joel M. Gross,

Chief, Environmental Enforcement Section,

Environment and Natural Resources Division.

[FR Doc. 98–18901 Filed 7–15–98; 8:45 am]

BILLING CODE 4410–15–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Importation of Controlled Substances;

Notice of Application

Pursuant to Section 1008 of the

Controlled Substances Import and

Export Act (21 U.S.C. 958(i)), the

Attorney General shall, prior to issuing

a registration under this Section to a

bulk manufacturer of a controlled

substance in Schedule I or II and prior

to issuing a regulation under Section

1002(a) authorizing the importation of

such a substance, provide

manufacturers holding registrations for

the bulk manufacture of the substance

an opportunity for a hearing.

Therefore, in accordance with Section

1301.34 of Title 21, Code of Federal

Regulations (CFR), notice is hereby

given that on May 19, 1998, Knight Seed

Company, Inc., 151 W. 126th Street,

Burnsville, Minnesota 55337, made

application by renewal to the Drug

Enforcement Administration to be

registered as an importer of marihuana

(7360), a basic class of controlled

substance listed in Schedule I.

This application is exclusively for the

importation of marihuana seed which

will be rendered non-viable and used as

bird seed.

Any manufacturer holding, or

applying for, registration as a bulk

manufacturer of this basic class of

controlled substance may file written

comments on or objections to the

application described above, and may,

at the same time, file a written request

for a hearing on such application in

accordance with 21 CFR 1301.43 in

such form as prescribed by 21 CFR

1316.47.

Any such comments, objections or

requests for a hearing may be addressed,

in quintuplicate, to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration, United States

Department of Justice, Washington, D.C.

20537, Attention: DEA Federal Register

Representative (CCR), and must be filed

no later than (30 days from publication).

This procedure is to be conducted

simultaneously with and independent

of the procedures described in 21 CFR

1301.34(b), (c), (d), (e), and (f). As noted

in a previous notice at 40 FR 43745–46

(September 23, 1975), all applicants for

registration to import a basic class of

any controlled substance in Schedule I

or II are and will continue to be required

to demonstrate to the Deputy Assistant

Administrator, Office of Diversion

Control, Drug Enforcement

Administration that the requirements

for such registration pursuant to 21

U.S.C. 958(a), 21 U.S.C. 823(a), and 21

CFR 1301.34(a), (b), (c), (d), (e), and (f)

are satisfied.

Dated: July 2, 1998.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 98–18894 Filed 7–15–98; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances; Notice of Registration

By Notice dated January 21, 1998, and

published in the Federal Register on

February 12, 1998, (63 FR 7181), Knoll

Pharmaceutical Company, 30 North

Jefferson Road, Whippany, New Jersey

07981, made application by renewal to

the Drug Enforcement Administration

(DEA) to be registered as a bulk

manufacturer of the basic classes of

controlled substances listed below:

Drug Schedule

Dihydromorphine (9145) ............... I

Hydromorphone (9150) ................ II

The firm plans to produce bulk

product and finished dosage units for

distribution to its customers.

DEA has considered the factors in 21

U.S.C. 823(a) and determined that the

registration of Knoll Pharmaceutical

Company to manufacture the listed

controlled substances is consistent with

the public interest at this time.

Therefore, pursuant to 21 U.S.C. 823

and 28 CFR 0.100 and 0.104, the Deputy

Assistant Administrator, Office of

Diversion Control, hereby orders that

the application submitted by the above

firm for registration as a bulk

manufacturer of the basic classes of

controlled substances listed above is

granted.

Dated: June 30, 1996.

John H. King,

Deputy Assistant Administrator, Office of

Diversion Control, Drug Enforcement

Administration.

[FR Doc. 98–18895 Filed 7–15–98; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Office of Justice Programs

[OJP (OJP)–1185]

RIN 1121–ZB22

State and Local Domestic

Preparedness Equipment Support

Program

AGENCY: Office of Justice Programs,

Office for State and Local Domestic

Preparedness Support (OSLDPS),

Justice.

ACTION: Request for proposals.

SUMMARY: The Office for State and Local

Domestic Preparedness Support is

soliciting grant applications from Chief

Executive Officers (CEO) in targeted

jurisdictions; e.g., selected counties and

cities, to fund the acquisition of certain

types of equipment in the following

categories: personal protective

equipment, and detection,

decontamination, and communications

equipment. This equipment will be

needed by first responders; i.e., fire

services, emergency medical services,

hazardous materials response units, and

law enforcement agencies, to respond to

a terrorist incident and the use of

weapons of mass destruction.

DATES: Applications for funding must be

received by the Office for State and

Local Domestic Preparedness Support

not later than July 17, 1998.

ADDRESSES: Applications must be

mailed to: Office for State and Local

Domestic Preparedness Support, 810 7th

St., NW, Washington, D.C. 20531.

FOR FURTHER INFORMATION CONTACT: The

National Criminal Justice Reference

Service (NCJRS) at 1–800–688–4252 or

the U.S. Department of Justice Response

Center at 1–800–421–6770.

SUPPLEMENTARY INFORMATION:

Authority

This action is authorized under Public

Law 105–119; the Departments of

Commerce, Justice, and State; the